Salzmann Peter's Form 4 filing
Immunovant, Inc. (IMVT) · filed Sep 1, 2023
- Accession no.
- 0001764013-23-000107
- Filed
- Sep 1, 2023
- Trade date
- Aug 30, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $1.25M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Salzmann PeterCIK 0001796309 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 30, 2023 | Common Stock | SSaleDisposed | −50,866 | $21.97 | −$1,117,526.02 | 975,873 | Direct | |
| Aug 30, 2023 | Common Stock | SSaleDisposed | −5,908 | $22.48 | −$132,811.84 | 969,965 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.